Everolimus - NDC Database (Page 4)
79 records found
Page: 4 Start a Discussion
67877-718 Nov 27, 2021
Everolimus .25 mg Oral Tablet by Ascend Laboratories, LLC
67877-719 Nov 27, 2021
Everolimus .5 mg Oral Tablet by Ascend Laboratories, LLC
67877-720 Nov 27, 2021
Everolimus .75 mg Oral Tablet by Ascend Laboratories, LLC
67877-721 Nov 27, 2021
Everolimus 1 mg Oral Tablet by Ascend Laboratories, LLC
70377-010 Oct 01, 2021
Everolimus 2.5 mg Oral Tablet by Biocon Pharma Inc.
70377-011 Oct 01, 2021
Everolimus 5 mg Oral Tablet by Biocon Pharma Inc.
70377-012 Oct 01, 2021
Everolimus 7.5 mg Oral Tablet by Biocon Pharma Inc.
70377-013 Oct 01, 2021
Everolimus 10 mg Oral Tablet by Biocon Pharma Inc.
70377-069 Jun 02, 2025
Everolimus .25 mg Oral Tablet by Biocon Pharma Inc.
70377-070 Jun 02, 2025
Everolimus .5 mg Oral Tablet by Biocon Pharma Inc.
70377-071 Jun 02, 2025
Everolimus .75 mg Oral Tablet by Biocon Pharma Inc.
70377-090 Jan 14, 2026
Everolimus 2 mg Oral Tablet, for Suspension by Biocon Pharma Inc.
70377-091 Jan 14, 2026
Everolimus 3 mg Oral Tablet, for Suspension by Biocon Pharma Inc.
70377-092 Jan 14, 2026
Everolimus 5 mg Oral Tablet, for Suspension by Biocon Pharma Inc.
70377-112 Jun 02, 2025
Everolimus 1 mg Oral Tablet by Biocon Pharma Inc.
72603-254 Oct 01, 2024
Everolimus 2.5 mg Oral Tablet by Northstar Rxllc
72603-255 Oct 01, 2024
Everolimus 5 mg Oral Tablet by Northstar Rxllc
72603-256 Oct 01, 2024
Everolimus 7.5 mg Oral Tablet by Northstar Rxllc
72603-257 Oct 01, 2024
Everolimus 10 mg Oral Tablet by Northstar Rxllc
Page: 4 Start a Discussion
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us .
